Open AccessClinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia
Author(s) -
Zhibin Wang,
Yu Ren,
Mingwei Li,
Weibo Huang,
Haiying Yao
Publication year - 2019
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.36.2.1168
Subject(s) - medicine , rituximab , cyclophosphamide , refractory (planetary science) , gastroenterology , statistical significance , surgery , chemotherapy , lymphoma , physics , astrobiology
To discuss clinical effect of different dosage of rituximab combined with cyclophosphamide in treatment of refractory immune thrombocytopenia (rITP).